keyboard_arrow_up

Global HIV-1 Infection Clinical Trials Market Review H2 2014

“HIV-1 Infection Global Clinical Trials Review, H2, 2014″ provides data on the HIV-1 Infection clinical trial scenario. This report provides elemental information and data relating to the clinical trials on HIV-1 Infection. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating HIV-1 Infection. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

List of Tables

HIV-1 Infection Therapeutics, Global, Clinical Trials by Region, 2014* 7

HIV-1 Infection Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8

HIV-1 Infection Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9

HIV-1 Infection Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10

HIV-1 Infection Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11

HIV-1 Infection Therapeutics Clinical Trials, North America, Top Countries, 2014* 12

HIV-1 Infection Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13

HIV-1 Infection Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14

Proportion of HIV-1 Infection to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15

HIV-1 Infection Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16

HIV-1 Infection Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17

Proportion of HIV-1 Infection to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18

HIV-1 Infection Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19

HIV-1 Infection Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20

HIV-1 Infection Therapeutics, Global, Clinical Trials by Phase, 2014* 21

HIV-1 Infection Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22

HIV-1 Infection Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23

HIV-1 Infection Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24

HIV-1 Infection Therapeutics, Global, Suspended Clinical Trials, 2014* 25

HIV-1 Infection Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26

HIV-1 Infection Therapeutics, Global, Terminated Clinical Trials, 2014* 28

HIV-1 Infection Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 34

HIV-1 Infection Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 35

HIV-1 Infection Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 36

HIV-1 Infection Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 37

HIV-1 Infection Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 38

HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 44

HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2014* 54

HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014* 61

HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2014* 66

HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 70

HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 74

HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014* 78

HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014* 82

HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2014* 85

HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen R&D Ireland, 2014* 87

HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 89

HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by French National Agency for Research on AIDS and Viral Hepatitis, 2014* 100

HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by AIDS Clinical Trials Group, 2014* 103

HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2014* 105

To get Discount on this report, visit: http://www.rnrmarketresearch.com/contacts/discount?rname=248723 .

This is a premium report priced at US$2500 for a single user PDF.

Scope

·         Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

·         Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

·         Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

·         Understand the dynamics of a particular indication in a condensed manner

·         Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

·         Obtain discontinued trial listing for trials across the globe

·         Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies